196 related articles for article (PubMed ID: 9839173)
21. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.
Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES
Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791
[TBL] [Abstract][Full Text] [Related]
22. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
23. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathologic characteristics and immunophenotypes of histiocytic necrotizing lymphadenitis: an analysis of 84 cases].
Du H; Shi Y; Shi Y
Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):86-90. PubMed ID: 26879428
[TBL] [Abstract][Full Text] [Related]
25. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
[TBL] [Abstract][Full Text] [Related]
26. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
27. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
28. Fas- and perforin-independent mechanism of cytotoxic T lymphocyte.
Kajino K; Kajino Y; Greene MI
Immunol Res; 1998; 17(1-2):89-93. PubMed ID: 9479571
[TBL] [Abstract][Full Text] [Related]
29. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
Kafrouni MI; Brown GR; Thiele DL
J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
[TBL] [Abstract][Full Text] [Related]
30. Perforin and granzyme B of cytotoxic T lymphocyte mediate apoptosis irrespective of Helicobacter pylori infection: possible act as a trigger of peptic ulcer formation.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2003; 50(54):1774-9. PubMed ID: 14696402
[TBL] [Abstract][Full Text] [Related]
31. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
32. Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways.
Smyth MJ; Sutton VR; Kershaw MH; Trapani JA
Transplantation; 1996 Nov; 62(10):1529-32. PubMed ID: 8958289
[TBL] [Abstract][Full Text] [Related]
33. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
[TBL] [Abstract][Full Text] [Related]
34. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection.
Lee JY; Chae DW; Kim SM; Nam ES; Jang MK; Lee JH; Kim HY; Yoo JY
J Viral Hepat; 2004 Mar; 11(2):130-5. PubMed ID: 14996347
[TBL] [Abstract][Full Text] [Related]
35. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.
Kehren J; Desvignes C; Krasteva M; Ducluzeau MT; Assossou O; Horand F; Hahne M; Kägi D; Kaiserlian D; Nicolas JF
J Exp Med; 1999 Mar; 189(5):779-86. PubMed ID: 10049941
[TBL] [Abstract][Full Text] [Related]
37. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.
Canaday DH; Wilkinson RJ; Li Q; Harding CV; Silver RF; Boom WH
J Immunol; 2001 Sep; 167(5):2734-42. PubMed ID: 11509617
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome.
Hashimoto S; Kobayashi A; Kooguchi K; Kitamura Y; Onodera H; Nakajima H
Am J Respir Crit Care Med; 2000 Jan; 161(1):237-43. PubMed ID: 10619826
[TBL] [Abstract][Full Text] [Related]
39. RKTS-33, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Hayashi Y; Osada H; Kataoka T
Biosci Biotechnol Biochem; 2005 Oct; 69(10):1923-8. PubMed ID: 16244443
[TBL] [Abstract][Full Text] [Related]
40. Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD).
Ciccocioppo R; Di Sabatino A; Parroni R; D'alò S; Pistoia MA; Doglioni C; Cifone MG; Corazza GR
Clin Exp Immunol; 2000 May; 120(2):235-40. PubMed ID: 10792370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
